University of Michigan Rogel Cancer Center (Adults and Pediatrics) — Ann Arbor, Michigan

Public research footprint of University of Michigan Rogel Cancer Center (Adults and Pediatrics), compiled from the ClinicalTrials.gov public registry.

260

Registered studies

186

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Ovarian Carcinoma · Recurrent Skin Squamous Cell Carcinoma With Sarcomatoid… · Anatomic Stage II Breast Cancer AJCC v8 · Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm

Recently updated registry entries

NCT07215910 — Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for… (Recruiting)
NCT04858334 — APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of Michigan Rogel Cancer Center (Adults and Pediatrics)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.